125 related articles for article (PubMed ID: 31399191)
1. JTE-607, a multiple cytokine production inhibitor, targets CPSF3 and inhibits pre-mRNA processing.
Kakegawa J; Sakane N; Suzuki K; Yoshida T
Biochem Biophys Res Commun; 2019 Oct; 518(1):32-37. PubMed ID: 31399191
[TBL] [Abstract][Full Text] [Related]
2. CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcoma.
Ross NT; Lohmann F; Carbonneau S; Fazal A; Weihofen WA; Gleim S; Salcius M; Sigoillot F; Henault M; Carl SH; Rodríguez-Molina JB; Miller HR; Brittain SM; Murphy J; Zambrowski M; Boynton G; Wang Y; Chen A; Molind GJ; Wilbertz JH; Artus-Revel CG; Jia M; Akinjiyan FA; Turner J; Knehr J; Carbone W; Schuierer S; Reece-Hoyes JS; Xie K; Saran C; Williams ET; Roma G; Spencer M; Jenkins J; George EL; Thomas JR; Michaud G; Schirle M; Tallarico J; Passmore LA; Chao JA; Beckwith REJ
Nat Chem Biol; 2020 Jan; 16(1):50-59. PubMed ID: 31819276
[TBL] [Abstract][Full Text] [Related]
3. Recent molecular insights into canonical pre-mRNA 3'-end processing.
Sun Y; Hamilton K; Tong L
Transcription; 2020 Apr; 11(2):83-96. PubMed ID: 32522085
[TBL] [Abstract][Full Text] [Related]
4. Anticancer benzoxaboroles block pre-mRNA processing by directly inhibiting CPSF3.
Tao Y; Budhipramono A; Huang J; Fang M; Xie S; Kim J; Khivansara V; Dominski Z; Tong L; De Brabander JK; Nijhawan D
Cell Chem Biol; 2024 Jan; 31(1):139-149.e14. PubMed ID: 37967558
[TBL] [Abstract][Full Text] [Related]
5. CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing.
Alahmari AA; Chaubey AH; Jonnakuti VS; Tisdale AA; Schwarz CD; Cornwell AC; Maraszek KE; Paterson EJ; Kim M; Venkat S; Gomez EC; Wang J; Gurova KV; Yalamanchili HK; Feigin ME
RNA; 2024 Feb; 30(3):281-297. PubMed ID: 38191171
[TBL] [Abstract][Full Text] [Related]
6. The anticancer compound JTE-607 reveals hidden sequence specificity of the mRNA 3' processing machinery.
Liu L; Yu AM; Wang X; Soles LV; Teng X; Chen Y; Yoon Y; Sarkan KSK; Valdez MC; Linder J; England W; Spitale R; Yu Z; Marazzi I; Qiao F; Li W; Seelig G; Shi Y
Nat Struct Mol Biol; 2023 Dec; 30(12):1947-1957. PubMed ID: 38087090
[TBL] [Abstract][Full Text] [Related]
7. A real-time fluorescence assay for CPSF73, the nuclease for pre-mRNA 3'-end processing.
Gutierrez PA; Baughman K; Sun Y; Tong L
RNA; 2021 Oct; 27(10):1148-1154. PubMed ID: 34230059
[TBL] [Abstract][Full Text] [Related]
8. JTE-607, a multiple cytokine production inhibitor, induces apoptosis accompanied by an increase in p21waf1/cip1 in acute myelogenous leukemia cells.
Tajima N; Fukui K; Uesato N; Maruhashi J; Yoshida T; Watanabe Y; Tojo A
Cancer Sci; 2010 Mar; 101(3):774-81. PubMed ID: 20028380
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 Tat increases the expression of cleavage and polyadenylation specificity factor 73-kilodalton subunit modulating cellular and viral expression.
Calzado MA; Sancho R; Muñoz E
J Virol; 2004 Jul; 78(13):6846-54. PubMed ID: 15194760
[TBL] [Abstract][Full Text] [Related]
10. CPSF3 Promotes Pre-mRNA Splicing and Prevents CircRNA Cyclization in Hepatocellular Carcinoma.
Huang Y; Ji H; Dong J; Wang X; He Z; Cheng Z; Zhu Q
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627085
[TBL] [Abstract][Full Text] [Related]
11. Clinical and veterinary trypanocidal benzoxaboroles target CPSF3.
Wall RJ; Rico E; Lukac I; Zuccotto F; Elg S; Gilbert IH; Freund Y; Alley MRK; Field MC; Wyllie S; Horn D
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9616-9621. PubMed ID: 30185555
[TBL] [Abstract][Full Text] [Related]
12. CSR1 induces cell death through inactivation of CPSF3.
Zhu ZH; Yu YP; Shi YK; Nelson JB; Luo JH
Oncogene; 2009 Jan; 28(1):41-51. PubMed ID: 18806823
[TBL] [Abstract][Full Text] [Related]
13. The poly A polymerase Star-PAP controls 3'-end cleavage by promoting CPSF interaction and specificity toward the pre-mRNA.
Laishram RS; Anderson RA
EMBO J; 2010 Dec; 29(24):4132-45. PubMed ID: 21102410
[TBL] [Abstract][Full Text] [Related]
14. On the Cutting Edge: Regulation and Therapeutic Potential of the mRNA 3' End Nuclease.
Liu H; Moore CL
Trends Biochem Sci; 2021 Sep; 46(9):772-784. PubMed ID: 33941430
[TBL] [Abstract][Full Text] [Related]
15. Metal-captured inhibition of pre-mRNA processing activity by CPSF3 controls
Swale C; Bougdour A; Gnahoui-David A; Tottey J; Georgeault S; Laurent F; Palencia A; Hakimi MA
Sci Transl Med; 2019 Nov; 11(517):. PubMed ID: 31694928
[No Abstract] [Full Text] [Related]
16. Elevated pre-mRNA 3' end processing activity in cancer cells renders vulnerability to inhibition of cleavage and polyadenylation.
Cui Y; Wang L; Ding Q; Shin J; Cassel J; Liu Q; Salvino JM; Tian B
Nat Commun; 2023 Aug; 14(1):4480. PubMed ID: 37528120
[TBL] [Abstract][Full Text] [Related]
17. JTE-607, a novel inflammatory cytokine synthesis inhibitor without immunosuppression, protects from endotoxin shock in mice.
Kakutani M; Takeuchi K; Waga I; Iwamura H; Wakitani K
Inflamm Res; 1999 Aug; 48(8):461-8. PubMed ID: 10493164
[TBL] [Abstract][Full Text] [Related]
18. JTE-607, a multiple cytokine production inhibitor, ameliorates disease in a SCID mouse xenograft acute myeloid leukemia model.
Uesato N; Fukui K; Maruhashi J; Tojo A; Tajima N
Exp Hematol; 2006 Oct; 34(10):1385-92. PubMed ID: 16982331
[TBL] [Abstract][Full Text] [Related]
19. Polyadenylation factor CPSF-73 is the pre-mRNA 3'-end-processing endonuclease.
Mandel CR; Kaneko S; Zhang H; Gebauer D; Vethantham V; Manley JL; Tong L
Nature; 2006 Dec; 444(7121):953-6. PubMed ID: 17128255
[TBL] [Abstract][Full Text] [Related]
20. Effects of a cytokine inhibitor, JTE-607, on the response to endotoxin in healthy human volunteers.
Borozdenkova S; Mant TG; Allen E; Pu K; Hoshino S; Jurcevic S
Int Immunopharmacol; 2011 Nov; 11(11):1837-43. PubMed ID: 21820084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
